News

esteller davalos merkel villasante

Two birds with one stone: a refined bioinformatic analysis can estimate gene copy-number variations from epigenetic data

A team led by Dr. Manel Esteller, Director of the Josep Carreras Leukaemia Research Institute, has improved the computational identification of potentially druggable gene amplifications in tumors, from epigenetic data. By using this new tool, scientists can have reliable information on the molecular data of a particular tumor, both at the genetics and epigenetics level, even from scarce samples.

Read more
Visita Ministra Diana Morant

The Josep Carreras Leukaemia Research Institute, has been selected by the National Cancer Institute for the Cancer Proteome Project with the support of the Spanish Ministry of Science and Innovation

The Josep Carreras Institute becomes part of the Cancer Proteome project, an international initiative for the study of malignant tumors. It has the support of the Spanish Ministry of Science and Innovation, whose Minister, Diana Morant, visited the Josep Carreras Institute on Thursday and announced a grant of one million euros to promote the project.

Read more
Grup Briones - Sant Pau

Phase I of Europe's first self-produced CAR-T30 clinical trial for Hodgkin's and non-Hodgkin's lymphoma ends

The first trial with a CAR-T immunotherapy drug produced in Sant Pau, a pioneer in Europe, for the treatment of classic Hodgkin's lymphoma and non-Hodgkin T lymphoma CD30 + in relapse or refractory, has successfully completed its Phase I . The project is led by Dr. Javier Briones, Head of the Clinical Hematology Unit of the Hematology Service of the Hospital de Sant Pau and Head of the Cell Immunotherapy and Gene Therapy Research Group of the Research Institute of the Hospital de Sant Pau - IIB-Sant Pau and the Josep Carreras Leukaemia Research Institute.

Read more

A Blood Test allows to differentiate severe COVID-19 from preeclampsia in pregnant women

The researchers team led by Dr. Marta Palomo, from the Josep Carreras Leukaemia Research Institute, and Dr. Fàtima Crispi, from BCNatal-IDIBAPS, has identified indicators which allow to differentiate both pathologies. In the framework of a project funded by the telethon Fundació La Marató of TV3, the outcome of this study opens the door to a more accurate diagnosis for both diseases and a better risk assessment. 

Read more